Back to search

France· FR:63833888

VIROPHTA, préparation pour collyre (lyophilisat et solvant)

A trifluridine product containing trifluridine, registered in France by HORUS PHARMA, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC S01AD02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVIROPHTA, préparation pour collyre (l…ATCS01AD02REGISTER NO.FR:63833888PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Trifluridine is registered in 4 of 19 countries.

Countries holding a registration under ATC S01AD02 (trifluridine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 3 of them publish a price we can compare per daily dose

Trifluridine · ATC S01AD02

4 / 19 countries

  • Franceprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TRIFLURIDINE
Manufacturer
HORUS PHARMA
Country
France (FR)
ATC code
S01AD02
ATC class
Trifluridine
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400932669684
    1 flacon(s) en verre de 0,05 g - 1 flacon(s) polyéthylène de 5 ml
    EUR 11.45

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/862a8253-21c6-4175-90f8-fddbb024ee2d
GET /v1/drugs/862a8253-21c6-4175-90f8-fddbb024ee2d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63833888",
  "date_amm": "1983-10-06",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "TRIFLURIDINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "lyophilisat et  solvant pour collyre",
  "voies_administration": "ophtalmique",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about trifluridine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.